Socioeconomic Burden of Pyogenic Liver Abscess Caused by Klebsiella Pneumoniae from a Teaching Hospital in East China

References

• Yin D, Ji C, Zhang S, et al. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: a 12-year retrospective study. Liver Int. 2021;41(4):810–818. doi:10.1111/liv.14760
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin C, Chang S, et al. Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000–2011. J Microbiol Immunol Infect. 2016;49(5):646–653. doi:10.1016/j.jmii.2014.08.028
   PubMedGoogle Scholar
• Law S, Li K. Older age as a poor prognostic sign in patients with pyogenic liver abscess. Int J Infect Dis. 2013;17(3):e177–84. doi:10.1016/j.ijid.2012.09.016
   PubMed Web of Science ®Google Scholar
• Qian Y, Wong C, Lai S, et al. A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015. Sci Rep. 2016;6:38587. doi:10.1038/srep38587
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768. doi:10.1001/jamaoncol.2019.2996
   PubMed Web of Science ®Google Scholar
• Cassini A, Plachouras D. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med. 2016;13(10):e1002150. doi:10.1371/journal.pmed.1002150
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xiao T, Wang Y, et al. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant enterobacteriaceae. Infect Drug Resist. 2021;14:5385–5393. doi:10.2147/IDR.S341664
   PubMed Web of Science ®Google Scholar
• Yang K, Xiao T, Shi Q, et al. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China. Antimicrob Resist Infect Control. J Glob Antimicrob Resist. 2021;26:101–107. doi:10.1016/j.jgar.2021.03.032
   PubMed Web of Science ®Google Scholar
• Kim YE, Jung YS, Ock M, et al. DALY estimation approaches: understanding and using the incidence-based approach and the prevalence-based approach. J Prev Med Public Health. 2022;55(1):10–18. doi:10.3961/jpmph.21.597
   PubMedGoogle Scholar
• Xiao T, Zhu Y, Zhang S, et al. A retrospective analysis of risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174–83. doi:10.1093/infdis/jiz559
   PubMed Web of Science ®Google Scholar
• Cho H, Lee ES, Lee YS, et al. Predictors of septic shock in initially stable patients with pyogenic liver abscess. Scand J Gastroenterol. 2017;52(5):589–594. doi:10.1080/00365521.2017.1288757
   PubMed Web of Science ®Google Scholar
• Chen W, Chen CH, Chiu KL, et al. Clinical outcome and prognostic factors of patients with pyogenic liver abscess requiring intensive care. Crit Care Med. 2008;36(4):1184–1188. doi:10.1097/CCM.0b013e31816a0a06
   PubMed Web of Science ®Google Scholar
• Peris J, Bellot P, Roig P, et al. Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study. BMC Geriatr. 2017;17(1):161. doi:10.1186/s12877-017-0545-x
   PubMedGoogle Scholar
• Chen S, Lee Y, Yen C, et al. Pyogenic liver abscess in the elderly: clinical features, outcomes and prognostic factors. Age Ageing. 2009;38(3):271–6; discussion. doi:10.1093/ageing/afp002
   PubMed Web of Science ®Google Scholar
• Liu JQ, Liu Y, Fu L, et al. Economic burden of 495 patients with liver abscess and influencing factors. Chin J Nosocomiol. 2021;31(01):91–94. doi:10.11816/cn.ni.2021-201756
   Google Scholar
• Humphries R, Bobenchik AM, Hindler JA, et al. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st Edition. J Clin Microbiol. 2021;59(12):e0021321. doi:10.1128/JCM.00213-21
   PubMed Web of Science ®Google Scholar
• National data. National Bureau of Statistics. Available from: https://data.stats.gov.cn/easyquer-y.htm?cn=C01. Accessed August 11, 2023.
   Google Scholar
• Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712–723.
   PubMed Web of Science ®Google Scholar
• Barnum H. Evaluating healthy days of life gained from health projects. Soc sci med. 1987;24(10):833–841.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Salomon JA, Mathers C. A critical examination of summary measures of population health. Bull World Health Organ. 2000;78(8):981–994.
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–337. doi:10.3350/cmh.2014.20.4.327
   PubMedGoogle Scholar
• Cassini A, Colzani E, Pini A, et al. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the burden of communicable diseases in Europe study, European Union and European economic area countries, 2009 to 2013. Euro Surveill. 2018;23(16):17–00454. doi:10.2807/1560-7917.ES.2018.23.16.17-00454
   PubMedGoogle Scholar
• Chan KS, Junnarkar SP, Low JK, et al. Aging is associated with prolonged hospitalisation stay in pyogenic liver abscess-a 1:1 propensity score matched study in elderly versus non-elderly patients. Malays. J Med Sci. 2022;29(5):59–73. doi:10.21315/mjms2022.29.5.7
   Google Scholar
• Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4(2):107–118. doi:10.4161/viru.22718
   PubMed Web of Science ®Google Scholar
• Siu LK, Yeh KM, Lin JC, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12(11):881–887. doi:10.1016/S1473-3099(12)70205-0
   PubMed Web of Science ®Google Scholar
• Chan KS, Chia CTW, Shelat VG. Demographics, radiological findings, and clinical outcomes of Klebsiella pneumonia vs. non-klebsiella pneumoniae pyogenic liver abscess: a systematic review and meta-analysis with trial sequential analysis. Pathogens. 2022;11(9):976. doi:10.3390/pathogens11090976
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang F, Wu P, et al. Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics. BMC Infect Dis. 2013;13:56. doi:10.1186/1471-2334-13-56
   PubMed Web of Science ®Google Scholar
• Lee J, Jang Y, Ahn S, et al. A retrospective study of pyogenic liver abscess caused primarily by Klebsiella pneumoniae vs. non-Klebsiella pneumoniae: CT and clinical differentiation. Abdom Radiol. 2020;45(9):2669–2679. doi:10.1007/s00261-019-02389-2
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang X, Wu Q, et al. Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob Resist Infect Control. 2019;8:166.
   PubMed Web of Science ®Google Scholar